High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers

BACKGROUND: Small cell lung cancer (SCLC) is an aggressive malignancy with a distinct natural history and dismal prognosis. SCLC is characterized as a recalcitrant neoplasm with limited therapeutic options and platinum-based chemotherapy is the treatment of choice. Programmed cell death-ligand 1(PD-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yih-Leong, Yang, Ching-Yao, Huang, Yen-Lin, Wu, Chen-Tu, Yang, Pan-Chyr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392304/
https://www.ncbi.nlm.nih.gov/pubmed/28152514
http://dx.doi.org/10.18632/oncotarget.14935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392304/
https://www.ncbi.nlm.nih.gov/pubmed/28152514
http://dx.doi.org/10.18632/oncotarget.14935

Ejemplares similares